Publication | Closed Access

A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules

Cannabis UseHealth SciencesFunctional SelectivityAddictionMedicinePharmacologyNeuropharmacologyChronic ModelNeurologyNeuroscienceMultiple SclerosisNeuroimmunologyCannabinoid PharmacologyCannabinoid Agonist InterferesCannabis